Back to search

Article

HILPDA: A Novel Prognostic Biomarker for Lung Adenocarcinoma Identified by Integrated Bioinformatic Analysis and Experimental Validation

2026-02-16

Abstract excerpt

<title>Abstract</title> <p> Background Lung adenocarcinoma (LUAD) represents the most prevalent pathological subtype of non-small cell lung cancer (NSCLC), a malignancy that accounts for 80–85% of all lung cancer cases. However, the expression profile of HILPDA and its functional significance in LUAD remain largely elusive. In this study, we sought to elucidate the regulatory mechanism of HILPDA in LUAD progres...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7ed0d6a-7f0b-5f93-b97d-190fffc47b98
DOI
10.21203/rs.3.rs-8572177/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HILPDA: A Novel Prognostic Biomarker for Lung Adenocarcinoma Identified by Integrated Bioinformatic Analysis and Experimental ValidationDOI 10.21203/rs.3.rs-8572177/v1
Select a neighboring publication to make it the new centre.